Research and Development

The Research and Development team at Beam Therapeutics focuses on advancing the innovative application of CRISPR base editing to create next-generation genetic medicines. This multidisciplinary group, consisting of experts in areas such as genomics, biophysics, and clinical biomarker development, collaborates to design, optimize, and validate therapeutic candidates while ensuring compliance with regulatory standards. Their work is integral to translating cutting-edge research into viable clinical applications, ultimately enhancing patient outcomes in genetic disorders.